Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

PhRMA Reorganizes PR; Policy VP Smith Will Also Head Communications

  • News

Executive Summary

PhRMA is combining its policy and communications efforts under Senior VP Richard Smith

You may also be interested in...



PhRMA Close To Deal With Tauzin; Changes In Reg Affairs, PR Line Up

The Pharmaceutical Research & Manufacturers of America is understood to be close to finalizing an agreement with Rep. Billy Tauzin (R-La.) to take over as the new CEO of the trade group

PhRMA Close To Deal With Tauzin; Changes In Reg Affairs, PR Line Up

The Pharmaceutical Research & Manufacturers of America is understood to be close to finalizing an agreement with Rep. Billy Tauzin (R-La.) to take over as the new CEO of the trade group

PhRMA Public Relations Changes Continue; Bello Overseeing Communications

The Pharmaceutical Research & Manufacturers of America's communications staff will be overseen by Judy Bello during the search for a new VP

Table

View full table

Related Content

Pink Sheet
Pink Sheet
Pink Sheet
Pink Sheet
Pink Sheet
Pink Sheet
Tags:
Latest Headlines

Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa

Partisan Politics Returns To US FDA Congressional Oversight

GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows

Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development

See All
UsernamePublicRestriction

Register

PS041621

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By